Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -10 of 16
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
10/17/2008
 
First Published:
12/22/2005
1.
Phase III Study of Radiotherapy and Amifostine OR Neoadjuvant Induction Chemotherapy Followed By Consolidation Chemoradiotherapy and Amifostine in Children With Newly Diagnosed Nasopharyngeal Carcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Active
18 and under
NCI
COG-ARAR0331
ARAR0331, NCT00274937
2.
Radiotherapy, Cetuximab, and Injections of TNFeradeā¢ Biologic for Elderly or Frail Patients With Head and Neck Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Active
Over 18
Pharmaceutical / Industry
UCIRB #14735B
GV-001.010 (TNF-ELF), NCT00496236
3.
Use of Cone Beam Kilovaltage Imaging in Patients Receiving Radiation Therapy for Head and Neck Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
18 and over
Other
06U.195
NCT00358007
4.
Docetaxel + Cetuximab + Concurrent Re-Irradiation (Intensity - Modulated Radiation Therapy, IMRT) for Patients With Locoregionally Recurrent Head and Neck Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
18 and over
Other
08-050
NCT00713219
5.
A Trial Using Velcade Plus Chemoradiation for Central Nervous System, Head and Neck, and Cervical Cancer Patients
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Active
18 and over
Other
05C.255
NCT00329589
Last Modified:
11/30/2006
 
First Published:
11/22/2006
6.
Phase I Randomized Pilot Study of Adjuvant Mutant p53 Peptide-Pulsed Dendritic Cell Vaccine With or Without T-Helper Peptides in Patients With Squamous Cell Carcinoma of the Head and Neck
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Active
Over 18
NCI
PCI-03-156
PCI-0507062, NCT00404339
7.
Phase I Study Using Sunitinib Plus Radiation Therapy for Cancer Patients
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Active
18 and over
Other
06C.549
NCT00437372
Last Modified:
5/7/2007
 
First Published:
5/1/2007
8.
Phase I Pilot Study of Photodynamic Therapy Comprising HPPH in Patients Undergoing Surgery For Primary or Recurrent Squamous Cell Cancer of the Head and Neck
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Active
18 and over
NCI
RPCI-I-74606
NCT00470496
First Published:
5/1/2008
9.
Phase I Study of Autologous or Allogeneic LMP-Specific Cytotoxic T-Lymphocytes in Patients With Epstein-Barr Virus (EBV)-Positive Lymphoma, Lymphoepithelioma, or Severe Chronic Active EBV Infection Syndrome
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Active
Any age
Other
BCM-H-9936-ALCI
H 9936, NCT00671164
10.
LMP1- and LMP2-Specific CTLs to Patients With EBV-Positive NPC (NATELLA)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Active
Not specified
Other
21000
NATELLA, NCT00516087
Select All on One Page
1
2
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute